New Insights into Cell Death and Drug Resistance in Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 67
Special Issue Editor
Interests: cancer; chemoresistance; signal transduction pathway; RTK (receptor tyrosine kinase); phytochemicals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Investigating drug resistance in cancer treatment is critical to reducing failure rates in cancer treatment and improving patient outcomes. This Special Issue, titled "Insights into cell death and drug resistance in cancer", explores the complex relationships among anti-cancer mechanisms, such as types of cell death, signal transduction pathways, and the emergence of drug resistance in cancer. Understanding the mechanisms involved in the acquisition of drug resistance in cancer cells is essential to overcoming cancer drug resistance and can also facilitate the development of effective therapeutic strategies. To summarize, elucidating the relationship between cell death and drug resistance could improve the effectiveness of cancer treatments, refine therapeutic approaches, and, ultimately, lead to better outcomes for cancer patients.
Dr. Chuhee Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- chemotherapy
- cell death
- drug resistance
- signal transduction pathways
